Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 18, 2018 - Issue 4
Submit an article Journal homepage
260
Views
2
CrossRef citations to date
0
Altmetric
Original Research

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study

Carlo LazzaroStudio di Economia Sanitaria, Milan, ItalyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-4795-1834View further author information
ORCID Icon,
Carlo BaronePoliclinico Gemelli, Rome, ItalyView further author information
,
Francesco CaprioniOspedale S. Martino, Genoa, ItalyView further author information
,
Stefano CascinuPoliclinico di Modena, Modena, ItalyView further author information
,
Alfredo FalconeAzienda Ospedaliera Universitaria Pisana, Pisa, ItalyView further author information
,
Evaristo MaielloCasa Sollievo della Sofferenza, S. Giovanni Rotondo, ItalyView further author information
,
Michele MilellaIstituto Nazionale Tumori Regina Elena, Rome, ItalyView further author information
,
Carmine PintoOspedale S. Maria Nuova, Reggio Emilia, ItalyView further author information
,
Michele ReniOspedale S. Raffaele, Milan, ItalyView further author information
&
Giampaolo TortoraAzienda Ospedaliera Universitaria Integrata Borgo Roma, Verona, ItalyView further author information
 show all
Pages 435-446 | Received 26 Jan 2018, Accepted 10 Apr 2018, Published online: 20 Apr 2018

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Briana M. Choi, Rachel B. Abraham, Hala Halawah, Matthias Calamia, Mavis Obeng-Kusi, Neda Alrawashdh, Daniel Arku & Ivo Abraham. (2021) Comparing jurisdiction-specific pharmaco-economic evaluations using medical purchasing power parities. Journal of Medical Economics 24:sup1, pages 34-41.
Read now
Jiaxing Huang, Weiting Liao, Jing Zhou, Pengfei Zhang, Feng Wen, Xinyuan Wang, Mengxi Zhang, Kexun Zhou, Qiuji Wu & Qiu Li. (2018) Cost-effectiveness analysis of adjuvant treatment for resected pancreatic cancer in China based on the ESPAC-4 trial. Cancer Management and Research 10, pages 4065-4072.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.